Physician profile
Brandon Specht
NPI 1538427141
$2,923.13
in general payments reported to CMS, 2019-2025
15 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,206 · 2020: $320 · 2021: $367 · 2022: $280 · 2023: $282 · 2024: $262 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $750.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $900.38 | 2019-2020 | |
| Abbvie INC. | $650.86 | 2023-2025 | |
| Integra Lifesciences Corporation | $210.15 | 2021 | |
| Axogen | $185.26 | 2020-2021 | |
| Allergan, INC. | $132.83 | 2019 | |
| Polarityte, INC. | $121.36 | 2020 | |
| Horizon Therapeutics Plc | $113.72 | 2019 | |
| Osiris Therapeutics INC. | $105.12 | 2019 | |
| Polynovo North America LLC | $103.34 | 2022 | |
| Heron Therapeutics, INC. | $99.64 | 2023 | Zynrelef |
| Musculoskeletal Transplant Foundation INC. | $96.11 | 2022 | |
| Ethicon US, LLC | $95.37 | 2021 | |
| Sientra, INC. | $80.10 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.76 | 2019 | |
| Kci USA, INC. | $11.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Specht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.